Page last updated: 2024-08-24

oseltamivir and Fever

oseltamivir has been researched along with Fever in 64 studies

Research

Studies (64)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (18.75)29.6817
2010's38 (59.38)24.3611
2020's14 (21.88)2.80

Authors

AuthorsStudies
Chon, I; Fujio, K; Hamabata, H; Jiaming, L; Kawashima, T; Kitano, A; Kodo, N; Masaki, H; Minato, M; Ono, Y; Phyu, WW; Saito, R; Saito, T; Sato, I; Shirahige, Y; Suzuki, E; Wagatsuma, K; Watanabe, H; Yuyang, S1
Ding, YL; Hu, CC; Li, WF; Yuan, B1
Bai, X; Chen, G; Fan, X; Li, Y; Tian, Y; Wang, K; Wang, W; Xi, S; Zhao, Y1
Hayashida, S; Morioka, I; Nagano, N; Nezu, K; Udagawa, S1
Hibino, A; Kondo, H; Mawatari, M; Odagiri, T; Saito, R; Shobugawa, Y; Tanabe, I; Yagami, R1
Bass, L; Cohen, A; Dowdell-Smith, CP; Foradori, D; Iacobas, I; Laufman, J; Owolabi, FS1
Akyollu, B; Arpali, E; Kocak, B; Tekin, S; Turkmen, A; Yelken, B1
Çapar, G; Köse, M; Medetalibeyoğlu, A; Şenkal, N; Tükek, T1
Bongard, E; Butler, CC; Cianci, D; Coenen, S; de Paor, M; Gobat, N; Goossens, H; Ieven, M; Saville, BR; van der Velden, AW; Verheij, TJ1
Firouzabadi, FD; Firouzabadi, MD; Ghalehbaghi, B; Goudarzi, S; Jahandideh, H; Roomiani, M1
Altunok, ES; Cengel, F; Ekin, EE; Gurkan, O; Yilmaz, A1
Chon, I; Kawashima, T; Kodo, N; Ono, Y; Osada, H; Phyu, W; Saito, R; Saito, T; Sato, I; Shimada, Y; Shobugawa, Y; Wagatsuma, K1
Bakheet, N; El-Shazly, M; Fouad, R; Hussin, W; Kassem, AM1
Aghavali, S; Babadi, M; Daraie, P; Emamikhah, M; Jalili, M; Mehrabani, M; Mohaghegh, F; Pouranian, M; Rohani, M; Zaribafian, M1
Aalipour, MA; Darazam, IA; Ghorbani, F; Pakdaman, H; Ramezani, M; Sagharichi, M; Simani, L1
Chen, RS; Chen, YM; Deng, L; He, CH; Liao, JY; Lin, CX; Lin, GY; Lin, JH; Liu, CY; Peng, Q; Wang, SJ; Zhang, T; Zheng, XF1
Liese, JG; Prifert, C; Sauerbrei, A; Schmidt-Ott, R; Streng, A; Weissbrich, B1
Bahirwani, J; Gonakoti, S; Maddala, RNM; Vidyasagar, S1
Beutels, P; Bongard, E; Brugman, C; Butler, CC; Chlabicz, S; Coenen, S; Colliers, A; Cook, J; Davies, M; de Jong, M; De Paor, M; De Sutter, A; Francis, NA; Glinz, D; Godycki-Ćwirko, M; Goossens, H; Holmes, J; Ieven, M; Lindbaek, M; Little, P; Martinón-Torres, F; Moragas, A; Munck Aabenhus, R; Pauer, J; Pfeiferová, M; Radzeviciene-Jurgute, R; Saville, B; Sundvall, PD; Torres, A; Touboul, P; van der Velden, AW; Varthalis, D; Verheij, T1
Barisione, G; Bruzzone, B; Butera, F; Grammatico, F; Guarona, G; Murdaca, G; Orsi, A; Schenone, S; Setti, M; Tisa, V1
Blazquez, D; Bueno, M; Calvo, C; Carrasco, J; Cilleruelo, MJ; de Blas, A; de José, MI; Escosa, L; García-García, ML; Guillén, S; Llorente, M; Mazagatos, D; Méndez-Echevarría, A; Otheo, E; Santos, M; Tarrago, A; Tomatis, C; Tovizi, M1
Ning, J1
de Briel, D; Heller, R; Martin, A; Martinot, M; Mohseni-Zadeh, M; Mothes, A; Sagot, E; Souply, L1
Bamba, M; Ichikawa, M; Ide, Y; Kawakami, C; Kawaoka, Y; Mitamura, K; Sakai-Tagawa, Y; Sugaya, N; Yamaguchi, Y; Yamazaki, M; Yasuhara, R1
Miyazaki, C; Momoi, M; Nakamura, Y; Ohkusa, Y; Okabe, N; Sugawara, T; Taniguchi, K1
Blaser, MJ; Buffa, R; Cabras, S; Contreras, M; Dominguez-Bello, MG; Hidalgo, G; Magris, M; Marini, E; Ortiz, V; Sanchez, W; Urbaez, M1
Chazono, K; Fukushima, A; Hashimoto, Y; Iwajima, Y; Maeda, Y; Ohsawa, M; Ono, H; Yamamoto, S1
Biçer, S; Ercan Sariçoban, H; Ergenekon Ulutaş, P; Gürol, Y; Özelgün, B; Özen, AO; Saf, C; Vitrinel, A; Yilmaz, G1
Azziz-Baumgartner, E; Blanco, N; Bonilla, L; Chacon, R; Clara, WA; Guzman, G; Jara, J; Minaya, P; Mirza, S; Moreno, L; Palekar, R; Paredes, A; Rodriguez, D; Then, CJ1
Andrianova, E; Averyanov, A; Bart, B; Epstein, O; Minina, E; Putilovskiy, M; Rafalsky, V1
Ichikawa, M; Kawakami, C; Kawaoka, Y; Mitamura, K; Sugaya, N; Tamura, D; Yamazaki, M1
Crawford, SM1
Hirotsu, N; Ikematsu, H; Iwaki, N; Kashiwagi, S; Kawai, N; Kawamura, K; Kawashima, T; Maeda, T; Matsuura, S; Nishimura, M; Tanaka, O; Yamauchi, S1
Chan, M; Chow, AL; Cui, L; Krishnan, P; Lee, CC; Leo, YS; Lim, PL; Ling, LM; Lye, DC; Tan, AS; Win, NN1
Bender, M; Bernheisel, C1
Baranovich, T; Dapat, C; Dapat, IC; Ishitani, N; Matsuda, R; Oguma, T; Saito, R; Sato, I; Suzuki, H; Suzuki, Y; Zaraket, H1
Lu, H; Shen, Y1
Bilgin, H; Odabas, D; Sert, A; Yazar, A1
Calitri, C; Cuozzo, M; Gabiano, C; Garazzino, S; Pinon, M; Scolfaro, C; Tovo, PA; Zoppo, M1
Amayiri, N; Madanat, F1
Hirotsu, N; Ikematsu, H; Iwaki, N; Kashiwagi, S; Kawai, N; Maeda, T; Matsuura, S; Nishimura, M; Tanaka, O; Yamauchi, S1
Dembiński, Ł; Jackowska, T; Marczyńska, M; Radzikowski, A; Smalisz-Skrzypczyk, K; Talarek, E1
Abid, S; Cuffari, C; Liu, D; Montecalvo, M; Nadelman, RB; Sandoval, C; Seiter, K; Shah, D; Shi, Q; Sinaki, B1
An, Y; Cao, B; Cao, ZX; Dong, JP; Gu, L; Guo, YM; He, XS; Hu, K; Jiang, LD; Li, XW; Liang, LR; Liang, ZA; Liu, QQ; Liu, YL; Sun, YH; Wang, C; Wang, YG; Wen, XM; Yang, T; Zou, ZQ1
Cho, HJ; Cho, YK; Kim, YN; Ma, JS1
Doniwa, K; Egashira, K; Hirotsu, N; Ikematsu, H; Iwaki, N; Iwakuni, O; Kashiwagi, S; Kawai, N; Kawashima, T; Kondou, K; Maeda, T; Tanaka, O; Yamaji, K1
Ajisaka, K; Ikematsu, H; Kashiwagi, K; Kashiwagi, S; Masui, S; Nabeshima, S; Takeoka, H1
Chang, LY; Huang, LM; Kao, CL; Lee, CY; Lee, PI; Lu, CY; Shao, PL; Tsou, TP; Yang, PC1
Duwe, S; Karsch, K; Louis, F; Muehlhans, S; Rath, B; Schweiger, B; Skopnik, H; Tief, F; Tuerk, E; von Kleist, M1
Hirotsu, N; Ikematsu, H; Iwaki, N; Kashiwagi, S; Kawai, N; Kawashima, T; Maeda, T; Ukai, H1
Blanchon, T; Carrat, F; Duval, X; Flahault, A; Leport, C; Mentré, F; Mosnier, A; Tibi, A; Tubach, F; Van der Werf, S1
Ali, NA; Haas, DM; Mangino, JE; Pan, X; Sopirala, MM; Turner, AN1
Choi, JS; Kim, KH; Lee, HJ; Shin, DH1
Andrianova, EN; Aver'ianov, AV; Babkin, AP; Bart, BIa; Epshteĭn, OI; Kostinov, MP; Kozyrev, OA; Minina, ES; Nechaev, VB; Petrov, DV; Putilovskiĭ, MA; Sel'kova, EP; Volchetskiĭ, AL1
Chen, XY; Cui, DJ; Gao, H; Hu, SL; Huo, ZL; Lin, JT; Wang, AX; Wang, YZ; Wu, XD; Yu, XZ; Zhu, JH; Zhu, SH1
Fukunaga, Y; Hajikano, M; Kawabata, K; Madenokouji, N; Matsuoka, K; Ninomiya, K1
Monto, AS; Ohmit, SE1
Hobo, S; Kondo, T; Matsumura, T; Tsujimura, K; Yamanaka, T1
Kubo, T; Nishimura, H1
Hirotsu, N; Horii, S; Ikematsu, H; Iwaki, N; Kanazawa, H; Kashiwagi, S; Kawai, N; Kawamura, K; Kawashima, T; Maeda, T; Nagai, T; Tanaka, O; Yamauchi, S1
Gejyo, F; Li, D; Oguma, T; Saito, R; Sakai, T; Sasaki, A; Sato, I; Sato, M; Shobugawa, Y; Suzuki, H; Suzuki, Y; Tanabe, N; Tsukada, H1
Ichihara, K; Suzuki, E1
Carr, JA; Hayden, FG; Ives, JA; Kelly, L; Lambkin, R; Mendel, DB; Oxford, JS; Roberts, NA; Tai, CY1

Reviews

3 review(s) available for oseltamivir and Fever

ArticleYear
[Overview of Meta-analysis of Lianhua Qingwen preparations in treatment of viral diseases].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2022, Volume: 47, Issue:16

    Topics: Cough; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Fatigue; Fever; Humans; Influenza, Human; Meta-Analysis as Topic; Nonprescription Drugs; Nucleic Acids; Oseltamivir; Ribavirin

2022
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
    Journal of neurovirology, 2021, Volume: 27, Issue:1

    Topics: Adult; Anticonvulsants; Ataxia; Azithromycin; Clonazepam; Cough; COVID-19; COVID-19 Drug Treatment; Dyspnea; Female; Fever; Humans; Hydroxychloroquine; Levetiracetam; Male; Middle Aged; Myalgia; Opsoclonus-Myoclonus Syndrome; Oseltamivir; SARS-CoV-2; Valproic Acid

2021
EMERGING PATHOGENS: INFLUENZA - H7N9.
    Disease-a-month : DM, 2017, Volume: 63, Issue:9

    Topics: Animals; Antiviral Agents; Birds; Communicable Diseases, Emerging; Cough; Fever; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza Vaccines; Influenza, Human; Oseltamivir; Poultry; Radiography, Thoracic; Respiratory Distress Syndrome; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction

2017

Trials

16 trial(s) available for oseltamivir and Fever

ArticleYear
Multicenter, randomized controlled, open label evaluation of the efficacy and safety of arbidol hydrochloride tablets in the treatment of influenza-like cases.
    BMC infectious diseases, 2023, Sep-06, Volume: 23, Issue:1

    Topics: Capsules; Fever; Humans; Influenza, Human; Nausea; Oseltamivir; Phosphates; Tablets

2023
Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018.
    The British journal of general practice : the journal of the Royal College of General Practitioners, 2020, Volume: 70, Issue:696

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Europe; Female; Fever; Headache; Humans; Influenza, Human; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Time Factors; Treatment Outcome; Young Adult

2020
[Efficacy and safety of oseltamivir in children with suspected influenza: a multicenter randomized open-label trial].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2017, Jun-02, Volume: 55, Issue:6

    Topics: Abdominal Pain; Antiviral Agents; Child; Diarrhea; Drug Administration Schedule; Female; Fever; Hospitals, Pediatric; Humans; Influenza, Human; Male; Oseltamivir; Treatment Outcome; Vomiting

2017
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC
    BMJ open, 2018, 07-12, Volume: 8, Issue:7

    Topics: Activities of Daily Living; Antiviral Agents; Cost-Benefit Analysis; Female; Fever; Headache; Hospitalization; Humans; Influenza, Human; Male; Multicenter Studies as Topic; Myalgia; Nonprescription Drugs; Oseltamivir; Pneumonia; Pragmatic Clinical Trials as Topic; Prescription Drugs; Self Care; Symptom Assessment; Time Factors

2018
Efficacy and safety of Ergoferon versus oseltamivir in adult outpatients with seasonal influenza virus infection: a multicenter, open-label, randomized trial.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016, Volume: 51

    Topics: Adolescent; Adult; Aged; Antibodies; Antiviral Agents; CD4 Antigens; Female; Fever; Histamine; Humans; Influenza, Human; Interferon-gamma; Male; Middle Aged; Oseltamivir; Outpatients; Quality of Life; Time Factors; Treatment Outcome; Young Adult

2016
Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
    Annals of internal medicine, 2011, Aug-16, Volume: 155, Issue:4

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Nausea; Oseltamivir; Prospective Studies; Virus Shedding; Vomiting; Young Adult

2011
A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:4

    Topics: Adult; Antiviral Agents; Cytokines; Drugs, Chinese Herbal; Enzyme Inhibitors; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Middle Aged; Neuraminidase; Oseltamivir; Statistics, Nonparametric; Treatment Outcome; Zanamivir

2012
Viral load and clinical features in children infected with seasonal influenza B in 2006/2007.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2012, Volume: 111, Issue:2

    Topics: Abdominal Pain; Adolescent; Age Factors; Antiviral Agents; Child; Child, Preschool; Chills; Female; Fever; Humans; Infant; Influenza B virus; Influenza, Human; Male; Musculoskeletal Pain; Oseltamivir; Prospective Studies; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Viral Load

2012
Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.
    Antiviral therapy, 2012, Volume: 17, Issue:6

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Cough; Drug Therapy, Combination; Enzyme Inhibitors; Family Characteristics; Female; Fever; Follow-Up Studies; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Middle Aged; Multivariate Analysis; Neuraminidase; Oseltamivir; Time Factors; Young Adult; Zanamivir

2012
[Ergoferon and oseltamivir in treatment of influenza: results of multicentre randomized comparative clinical trial].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2012, Volume: 57, Issue:7-8

    Topics: Adolescent; Adult; Antipyretics; Antiviral Agents; Body Temperature; CD4 Antigens; Female; Fever; Histamine; Humans; Influenza, Human; Interferon-gamma; Male; Middle Aged; Oseltamivir; Russia; Time Factors; Treatment Outcome; Young Adult

2012
[A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2004, Volume: 27, Issue:7

    Topics: Acetamides; Adult; Antiviral Agents; Double-Blind Method; Drug Administration Schedule; Female; Fever; Heart Diseases; Humans; Influenza, Human; Male; Middle Aged; Oseltamivir; Respiratory Tract Diseases; Treatment Outcome

2004
Efficacy of oseltamivir phosphate to horses inoculated with equine influenza A virus.
    The Journal of veterinary medical science, 2006, Volume: 68, Issue:9

    Topics: Acetamides; Animals; Bronchoalveolar Lavage Fluid; Female; Fever; Horse Diseases; Horses; Influenza A Virus, H3N8 Subtype; Lung; Male; Orthomyxoviridae Infections; Oseltamivir; Time Factors

2006
Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2007, Volume: 14, Issue:2-3

    Topics: Administration, Oral; Adolescent; Analgesics, Non-Narcotic; Antiviral Agents; Child; Child, Preschool; DNA Primers; DNA, Viral; Drugs, Chinese Herbal; Female; Fever; Humans; Infant; Influenza A virus; Influenza, Human; Japan; Male; Medicine, Chinese Traditional; Oseltamivir; Phytotherapy; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome

2007
A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.
    The Journal of infection, 2008, Volume: 56, Issue:1

    Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Female; Fever; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Japan; Male; Oseltamivir; Treatment Outcome; Zanamivir

2008
Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City, Japan.
    The Tohoku journal of experimental medicine, 2008, Volume: 214, Issue:2

    Topics: Alphainfluenzavirus; Body Temperature; Child; Cities; Demography; Female; Fever; Humans; Influenza B virus; Influenza, Human; Japan; Male; Multivariate Analysis; Oseltamivir; Seasons; Time Factors; Treatment Outcome

2008
The course of fever following influenza virus infection in children treated with oseltamivir.
    Journal of medical virology, 2008, Volume: 80, Issue:6

    Topics: Age Factors; Antiviral Agents; Body Temperature; Child; Child, Preschool; Female; Fever; Humans; Infant; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Japan; Male; Oseltamivir; Regression Analysis; Time Factors; Treatment Outcome

2008

Other Studies

45 other study(ies) available for oseltamivir and Fever

ArticleYear
Duration of fever and symptoms in influenza-infected children treated with baloxavir marboxil during the 2019-2020 season in Japan and detection of influenza virus with the PA E23K substitution.
    Antiviral research, 2022, Volume: 201

    Topics: Adolescent; Antiviral Agents; Child; Dibenzothiepins; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Morpholines; Nucleotidyltransferases; Oseltamivir; Pyridones; Seasons; Triazines

2022
Early Fever Resolution in Early Childhood Influenza Treated with Baloxavir Marboxil: A Retrospective Study Compared to Those with Oseltamivir.
    Medicina (Kaunas, Lithuania), 2023, Aug-25, Volume: 59, Issue:9

    Topics: Child; Child, Preschool; Dibenzothiepins; Fever; Humans; Influenza, Human; Oseltamivir; Retrospective Studies

2023
Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.
    PloS one, 2019, Volume: 14, Issue:11

    Topics: Adolescent; Child; Child, Preschool; Drug Approval; Enzyme Inhibitors; Fever; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Multivariate Analysis; Mutation; Neuraminidase; Oseltamivir; Proportional Hazards Models; Seasons; Temperature; Treatment Outcome; Young Adult

2019
Weakness, Anemia, and Neutropenia in a 9-Year-Old Girl With Influenza.
    Pediatrics, 2020, Volume: 145, Issue:4

    Topics: Anemia; Antiviral Agents; Child; Diagnosis, Differential; Fatigue; Female; Fever; Gait Disorders, Neurologic; Humans; Influenza, Human; Muscle Weakness; Neutropenia; Oseltamivir; Spinal Cord Diseases; Vitamin B 12 Deficiency; Vomiting

2020
Case report: A kidney transplant patient with mild COVID-19.
    Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:4

    Topics: Adult; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; Disease Management; Female; Fever; Glucocorticoids; Graft Rejection; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lupus Nephritis; Oseltamivir; Pandemics; Pneumonia, Viral; Prednisone; SARS-CoV-2; Severity of Illness Index; Tacrolimus

2020
Characteristics of the initial patients hospitalized for COVID-19: a single-center report
    Turkish journal of medical sciences, 2020, Aug-26, Volume: 50, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Antihypertensive Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; Female; Fever; Health Personnel; Humans; Hydroxychloroquine; Hypertension; Intensive Care Units; Lung; Male; Middle Aged; Myalgia; Oseltamivir; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Travel; Turkey; Young Adult

2020
Have the symptoms of patients with COVID-19 changed over time during hospitalization?
    Medical hypotheses, 2020, Volume: 143

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coronavirus Infections; Cough; COVID-19; Diarrhea; Dyspnea; Female; Fever; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Symptom Assessment; Young Adult

2020
COVID-19 Pulmonary Infection with Pneumothorax in a Young Patient.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2020, Volume: 30, Issue:6

    Topics: Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus; Coronavirus Infections; Cough; COVID-19; Enoxaparin; Female; Fever; Humans; Hydroxychloroquine; Lung; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Pneumothorax; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2020
Duration of fever and symptoms in children after treatment with baloxavir marboxil and oseltamivir during the 2018-2019 season and detection of variant influenza a viruses with polymerase acidic subunit substitutions.
    Antiviral research, 2020, Volume: 183

    Topics: Adolescent; Amino Acid Substitution; Antiviral Agents; Child; Child, Preschool; Dibenzothiepins; Female; Fever; Genetic Variation; Humans; Influenza A virus; Influenza, Human; Male; Morpholines; Oseltamivir; Prospective Studies; Pyridones; RNA-Dependent RNA Polymerase; Seasons; Triazines; Viral Proteins

2020
Persistent hiccup: A rare presentation of COVID-19.
    Respiratory investigation, 2021, Volume: 59, Issue:2

    Topics: Baclofen; Biomarkers; COVID-19; COVID-19 Testing; Fever; Hiccup; Humans; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pharyngitis; Rare Diseases; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography

2021
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
    Journal of neurovirology, 2021, Volume: 27, Issue:1

    Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations; Dyspnea; Fatigue Syndrome, Chronic; Female; Fever; Humans; Hydroxychloroquine; Lopinavir; Male; Middle Aged; Oseltamivir; Research Design; Ritonavir; SARS-CoV-2; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Survivors

2021
Subtype-specific Clinical Presentation, Medical Treatment and Family Impact of Influenza in Children 1-5 Years of Age Treated in Outpatient Practices in Germany During Three Postpandemic Years, 2013-2015.
    The Pediatric infectious disease journal, 2018, Volume: 37, Issue:9

    Topics: Antiviral Agents; Bronchitis; Child, Preschool; Epidemiological Monitoring; Female; Fever; Germany; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Male; Multiplex Polymerase Chain Reaction; Oseltamivir; Outpatients; Pandemics; Pharyngitis; Prospective Studies; Respiratory Tract Infections; Seasons

2018
A case of H3N2 complicated by acute kidney injury secondary to rhabdomyolysis.
    BMJ case reports, 2018, Apr-18, Volume: 2018

    Topics: Acute Kidney Injury; Aged, 80 and over; Antiviral Agents; Bronchodilator Agents; Cough; Fever; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Methylprednisolone; Myalgia; Oseltamivir; Respiratory Distress Syndrome; Rhabdomyolysis; Treatment Outcome

2018
Detection of influenza A(H1N1)pdm09 virus in a patient travelling from Shanghai to Italy in July 2018: an uncommon clinical presentation in a non-seasonal period.
    Journal of preventive medicine and hygiene, 2019, Volume: 60, Issue:1

    Topics: Adult; Antiviral Agents; China; Communicable Diseases, Imported; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Italy; Leukopenia; Male; Oseltamivir; Phylogeny; Seasons

2019
Oseltamivir treatment for influenza in hospitalized children without underlying diseases.
    The Pediatric infectious disease journal, 2013, Volume: 32, Issue:10

    Topics: Analysis of Variance; Antiviral Agents; Chi-Square Distribution; Child, Preschool; Female; Fever; Hospitalization; Humans; Infant; Influenza, Human; Length of Stay; Male; Oseltamivir; Retrospective Studies

2013
Diagnosis and treatment of children with severe influenza A from the 2009/2010 pandemic in Tianjin, China.
    Tropical doctor, 2014, Volume: 44, Issue:2

    Topics: Administration, Intravenous; Adolescent; Antiviral Agents; Child; Child, Preschool; China; Female; Fever; Glucocorticoids; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Methylprednisolone; Oseltamivir; Pandemics; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Severity of Illness Index; Treatment Outcome

2014
Contribution of systematic RT-PCR screening for influenza during the epidemic season.
    Medecine et maladies infectieuses, 2014, Volume: 44, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Cross Infection; Delayed Diagnosis; Diagnosis, Differential; Disease Outbreaks; Emergency Service, Hospital; Female; Fever; France; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Lung Diseases; Male; Middle Aged; Oseltamivir; Patients' Rooms; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Seasons; Sensitivity and Specificity

2014
Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
    Antiviral therapy, 2015, Volume: 20, Issue:1

    Topics: Acids, Carbocyclic; Antiviral Agents; Child; Child, Preschool; Cyclopentanes; Enzyme Inhibitors; Female; Fever; Guanidines; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Neuraminidase; Oseltamivir; Pyrans; Severity of Illness Index; Sialic Acids; Time Factors; Treatment Outcome; Viral Proteins; Virus Shedding; Zanamivir

2015
Abnormal behavior during influenza in Japan during the last seven seasons: 2006-2007 to 2012-2013.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:12

    Topics: Antiviral Agents; Behavioral Symptoms; Child; Fever; Humans; Influenza, Human; Japan; Oseltamivir; Retrospective Studies

2014
Effect of influenza-induced fever on human bioimpedance values.
    PloS one, 2015, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Antiviral Agents; Body Composition; Child; Child, Preschool; Disease Outbreaks; Electric Impedance; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Venezuela; Young Adult

2015
Oseltamivir produces hypothermic and neuromuscular effects by inhibition of nicotinic acetylcholine receptor functions: comparison to procaine and bupropion.
    European journal of pharmacology, 2015, Sep-05, Volume: 762

    Topics: Animals; Bradycardia; Bupropion; Drug Synergism; Fever; Hypotension; Male; Mice; Muscle Relaxation; Neuromuscular Agents; Nicotinic Antagonists; Oseltamivir; Procaine; Rats; Receptors, Nicotinic

2015
Experience of influenza A H1N1 in a paediatric emergency unit.
    Le infezioni in medicina, 2015, Volume: 23, Issue:2

    Topics: Antiviral Agents; Child; Child, Preschool; Diarrhea; Emergency Service, Hospital; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lymphopenia; Male; Myalgia; Oseltamivir; Retrospective Studies; Risk Factors; Treatment Outcome; Turkey

2015
Demographic and clinical characteristics of deaths associated with influenza A(H1N1) pdm09 in Central America and Dominican Republic 2009-2010.
    BMC public health, 2015, Jul-31, Volume: 15

    Topics: Adolescent; Adult; Antiviral Agents; Asthma; Central America; Comorbidity; Costa Rica; Disease Outbreaks; Dominican Republic; El Salvador; Female; Fever; Guatemala; Honduras; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Nicaragua; Oseltamivir; Pregnancy; Pulmonary Disease, Chronic Obstructive; Young Adult

2015
Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Aug-01, Volume: 47, Issue:3

    Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Fever; Humans; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Oseltamivir; Retrospective Studies; Treatment Outcome; Zanamivir

2008
A/H1N1 flu pandemic. Managing neutropenic sepsis.
    BMJ (Clinical research ed.), 2009, Sep-29, Volume: 339

    Topics: Antineoplastic Agents; Antiviral Agents; Diagnosis, Differential; Fever; Humans; Infection Control; Influenza A Virus, H1N1 Subtype; Influenza, Human; Neoplasms; Neutropenia; Oseltamivir

2009
Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Dec-15, Volume: 49, Issue:12

    Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Enzyme Inhibitors; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Mutation; Neuraminidase; Oseltamivir; Time Factors; Zanamivir

2009
Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Apr-01, Volume: 50, Issue:7

    Topics: Adult; Antiviral Agents; Cohort Studies; Disease Outbreaks; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Singapore; Statistics, Nonparametric; Virus Shedding; Young Adult

2010
Fever, cough, and hypoxia in a pregnant woman.
    The Journal of family practice, 2010, Volume: 59, Issue:4

    Topics: Adult; Antiviral Agents; Cough; Female; Fever; Humans; Hypoxia; Influenza A Virus, H1N1 Subtype; Oseltamivir; Oxygen Inhalation Therapy; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Vomiting

2010
Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.
    The Pediatric infectious disease journal, 2010, Volume: 29, Issue:10

    Topics: Adolescent; Amino Acid Substitution; Antiviral Agents; Child; Child, Preschool; Drug Resistance, Viral; Female; Fever; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Male; Microbial Sensitivity Tests; Mutation, Missense; Nasopharynx; Neuraminidase; Oseltamivir; Treatment Outcome; Viral Proteins; Zanamivir

2010
Pandemic (H1N1) 2009, Shanghai, China.
    Emerging infectious diseases, 2010, Volume: 16, Issue:6

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; China; Disease Outbreaks; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Population Surveillance; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; RNA, Viral; Time Factors; Travel

2010
An unusual cause of fever in a neonate: influenza A (H1N1) virus pneumonia.
    Pediatric pulmonology, 2010, Volume: 45, Issue:7

    Topics: Antiviral Agents; Fever; Gentamicins; Humans; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Zanamivir

2010
Clinical features of hospitalised children with 2009 H1N1 influenza virus infection.
    European journal of pediatrics, 2010, Volume: 169, Issue:12

    Topics: Adolescent; Antiviral Agents; Child; Child, Hospitalized; Child, Preschool; Cough; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Italy; Lung Diseases; Male; Medical Records; Nervous System Diseases; Oseltamivir; Treatment Outcome

2010
Retrospective analysis of pediatric cancer patients diagnosed with the pandemic H1N1 influenza infection.
    Pediatric blood & cancer, 2011, Volume: 56, Issue:1

    Topics: Adolescent; Child; Child, Preschool; Fever; Hematologic Neoplasms; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Neoplasms; Oseltamivir; Pandemics; Retrospective Studies; Time Factors; Young Adult

2011
Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Antiviral Agents; Enzyme Inhibitors; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Neuraminidase; Oseltamivir; Pandemics; Seasons; Young Adult; Zanamivir

2011
[Clinical course of influenza A(H1N1)v in children treated in Warsaw in season 2009/2010].
    Przeglad epidemiologiczny, 2010, Volume: 64, Issue:4

    Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Communicable Diseases, Emerging; Comorbidity; Cough; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumonia; Poland; Retrospective Studies; Seasons; Treatment Outcome; Urban Population

2010
Prospective evaluation of 2009 H1N1 influenza A in patients admitted with fever to an oncology unit.
    Infection control and hospital epidemiology, 2011, Volume: 32, Issue:8

    Topics: Adult; Antiviral Agents; Child; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Middle Aged; Neoplasms; Oncology Service, Hospital; Oseltamivir; Prospective Studies; Treatment Outcome

2011
Clinical significance of pleural effusion in the new influenza A (H1N1) viral pneumonia in children and adolescent.
    Pediatric pulmonology, 2012, Volume: 47, Issue:5

    Topics: Adolescent; Antistreptolysin; Antiviral Agents; C-Reactive Protein; Child; Child, Preschool; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Length of Stay; Lymphopenia; Male; Oseltamivir; Oxygen Inhalation Therapy; Pleural Effusion; Pneumonia, Viral; Retrospective Studies; Severity of Illness Index

2012
Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:2

    Topics: Adolescent; Adult; Antiviral Agents; Child; Drug Resistance, Viral; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Inhibitory Concentration 50; Japan; Male; Mutation; Oseltamivir; Pandemics; Seasons; Sequence Analysis, DNA; Treatment Outcome; Virus Shedding; Young Adult

2012
Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.
    The Pediatric infectious disease journal, 2012, Volume: 31, Issue:9

    Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Drug Resistance, Viral; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Kaplan-Meier Estimate; Male; Oseltamivir; Prospective Studies; Viral Load

2012
Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.
    Influenza and other respiratory viruses, 2013, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Enzyme Inhibitors; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Inhibitory Concentration 50; Male; Middle Aged; Neuraminidase; Oseltamivir; Seasons; Severity of Illness Index; Treatment Outcome; Young Adult; Zanamivir

2013
Effect of fever on hospital presentation, diagnosis, and treatment in patients with H1N1/09 influenza.
    Journal of hospital medicine, 2013, Volume: 8, Issue:1

    Topics: Adult; Antiviral Agents; Comorbidity; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Male; Middle Aged; Ohio; Oseltamivir; Outcome Assessment, Health Care; Patient Admission; Retrospective Studies; Tertiary Care Centers; Time Factors; United States

2013
Leukocytoclastic vasculitis associated with influenza A virus infection.
    Journal of Korean medical science, 2012, Volume: 27, Issue:12

    Topics: Anti-Inflammatory Agents; Antiviral Agents; Child, Preschool; Female; Fever; Humans; Influenza A virus; Influenza, Human; Nasopharynx; Oseltamivir; Prednisolone; Reverse Transcriptase Polymerase Chain Reaction; Skin; Vasculitis, Leukocytoclastic, Cutaneous

2012
Frequency and effects of bacterial infection in children with influenza under oseltamivir treatment.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2006, Volume: 73, Issue:3

    Topics: Acetamides; Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Female; Fever; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Japan; Male; Oseltamivir; Pneumococcal Infections; Superinfection; Time Factors

2006
Symptomatic predictors of influenza virus positivity in children during the influenza season.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Sep-01, Volume: 43, Issue:5

    Topics: Acetamides; Aging; Antiviral Agents; Child; Child, Preschool; Cough; Fever; Guanidines; Headache; Humans; Infant; Influenza, Human; Logistic Models; Muscular Diseases; Odds Ratio; Oseltamivir; Pyrans; Risk Factors; Seasons; Sialic Acids; Zanamivir

2006
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
    Antiviral research, 2002, Volume: 55, Issue:2

    Topics: Acetamides; Amino Acid Substitution; Animals; Antiviral Agents; Body Weight; Cell Line; Disease Models, Animal; Drug Resistance, Viral; Ferrets; Fever; Humans; In Vitro Techniques; Inflammation; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mice; Mice, Inbred BALB C; Mutagenesis, Site-Directed; Mutation; Neuraminidase; Oseltamivir; Sequence Analysis, DNA; Virus Replication

2002